Close Menu

NEW YORK – Roche announced Tuesday its Accu-Check SugarView app, a blood glucose monitor designed to help non-insulin-dependent patients with type 2 diabetes manage their condition between doctors' visits, received the CE mark. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.